Document is current

Article History

Accepted: 1 July 2024

First Online: 18 July 2024

Declarations

:

: TFK reports being the speaker for Amgen, MSD, BMS, Roche and Bayer; being on the Advisory Board of MSD, AstraZeneca and Beigene; received Grant from GILEAD and Other from Lilly, MSD, Roche and BMS. FRH reports being on the Advisory Board, being a speaker, receiving Grant and non-financial support from MSD, AstraZeneca and Servier. He also reports being on the Advisory Board, being a speaker and receiving non-financial support from BMS, Astellas, Lilly and Roche; Advisory Board from Daiichi Sankyo; Advisory Board, speaker from Merck and Sanofi-Aventis and Advisory Board—Speaker—Grant from Amgen. AFM reports being on the Advisory Board, Speaker from BMS, MSD and Lilly. FLM reports being on the Advisory Board, being a speaker and other from Roche, Amgen, Servier, Lilly, BMS and MSD. MAM reports being on the Advisory Board from Amgen, AstraZeneca and Dragonfly Therapeutics; Advisory Board and Speaker from Beigene, Novartis, BMS and MSD; Speaker from Lilly and Grant from Merck. MMR reports personal feels from Amgen. JGP reports Advisory Board role and speaker from Elli Lilly, BMS and Servier; Advisory Board from MSD and Astellas and Other from AstraZeneca and other. ACB reports other from Merck and Speaker from BMS. ABCC and PARA have nothing to disclose.

: Compliance with ethical standards. The current study has been performed in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki and its later amendments.